Peripheral neurodegenerative and neuroprotective biomarker signatures in Parkinson’s disease with and without freezing of gait

Read full text Summarise with VIRAT
Authors: Yağmur İnalkaç Gemici, Melike Batum, Fatih Rıza Çelik, Zeynep Zerrin Göz, Muhammet Nurullah Yiğit, Cevval Ulman, Hatice Maviogöu
Cited by: 0
References: 41

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract Background Neuroinflammation and glial dysfunction are increasingly recognized as key contributors to Parkinson’s disease (PD) pathology. However, the relationship between circulating neurodegeneration-related biomarkers and freezing of gait (FOG), a disabling motor complication, remains unclear. Results This cross-sectional study included 46 PD patients (22 with FOG, 24 without) and 14 age- and sex-matched controls. Serum concentrations of neurofilament light chain (NfL), glial fibrillary acidic protein (GFAP), soluble triggering receptor expressed on myeloid cells-2 (sTREM-2), and neuregulin-1 (NRG-1) were measured via ELISA. A composite Inflammatory Load Index (ILI) was constructed from CRP, ESR, NLR, HDL, and uric acid values. Clinical severity was assessed using Unified Parkinson’s Disease Rating Scale (UPDRS), Hoehn and Yahr (HY) scale, Parkinson’s Disease Questionnaire-39 (PDQ-39), and the Freezing of Gait Questionnaire (FOG-Q) scales.Compared with controls, PD patients showed significantly elevated serum NfL and GFAP levels and reduced NRG-1 levels (all p < 0.01). Within PD, no significant differences were observed for NfL, GFAP, or sTREM-2 between freezing and non-freezing subgroups. Interestingly, serum NRG-1 levels were higher in the FOG group ( p = 0.031) despite comparable inflammatory indices. In adjusted models, NRG-1 showed a significant main effect for FOG status (F(1, 37) = 4.65, p = 0.037). Conclusion These findings highlight distinct peripheral biomarker signatures in PD, indicating widespread axonal and astroglial injury alongside impaired trophic signaling. The elevated NRG-1 levels in FOG may represent a phenotype-specific, compensatory neuroprotective response rather than a marker of inflammation. Future longitudinal studies integrating serum and CSF biomarkers with imaging and mechanistic analyses are warranted to validate these observations.

Fields of Study & Subjects

Parkinson's Disease Mechanisms and Treatments Neuroinflammation and Neurodegeneration Mechanisms Deep Brain Stimulation and Movement Disorders

Publication details

Journal / source
The Egyptian Journal of Neurology Psychiatry and Neurosurgery
Volume
62
Issue
1
Publication date
18 March 2026
Language
EN